CD274 and neoplasm: Due to the complexity of the tumour microenvironment, it is unlikely that non-invasive [18F]FDG-PET/CT metabolic parameters will replace immunohistochemical techniques, or other direct PD-L1 measurement methods alone, but they may supplement them, for example as part of a predictive marker nomogram alongside patient and biological characteristics.